Evidence map›Paper›PMID 11547902›Full record

ReviewJournal of mammary gland biology and neoplasia2001

MUC1, the renaissance molecule.

S J Gendler

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 229 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
229citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

229 citing papers in PubMed, 3 syntheses or guidelines pooled it, 560 citations in OpenAlex.

  1. Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Tumor biomarkers for diagnosis, prognosis and targeted therapy.Signal transduction and targeted therapy · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. MUC21: a new target for tumor treatment.Frontiers in oncology · 2024
    Review
  20. Article

169 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S J GendlerDepartment of Biochemistry and Molecular Biology, Mayo Clinic Scottsdale, Arizona 85259, USA. gendler.sandra@mayo.edu
Mayo Clinic in Arizona · US

Funding

Functional Study of Mucin MUC1R01CA064389 · NCI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI GENDLER, SANDRA J · 1994 to 2014
$4.9M
MUCI EFFECTS ON BREAST DEVELOPMENT AND TUMORIGENESISF32CA081703 · NCI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI SCHROEDER, JOYCE A · 1999 to 2001
$80k
NCI NIH HHS CA64389NCI NIH HHS CA81703NHLBI NIH HHS HL07897
6 · The paper itself

Abstract

MUC1 is a large, heavily glycosylated mucin expressed on the apical surfaces of most simple, secretory epithelia including the mammary gland, gastrointestinal, respiratory, urinary and reproductive tracts. Although MUC1 was thought to be an epithelial-specific protein, it is now known to be expressed on a variety of hematopoietic cells as well. Mucins function in protection and lubrication of epithelial surfaces. Transmembrane mucins, which contain cytoplasmic tail domains, appear to have additional functions through their abilities to interact with many proteins involved in signal transduction and cell adhesion. The goal of this review is to highlight recent discoveries that suggest that MUC1 may be a multifunctional protein, located on the surfaces of cells as a sensor of the environment, poised to signal to the interior when things go awry.

Indexed as

AnimalsBreast NeoplasmsFemaleHumansMammary Neoplasms, ExperimentalMucin-1Mucin-1

Identifiers

PMID11547902
OpenAlexW28705092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.